Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis

Green, Jessica Emily, Wrobel, Anna, Todd, Emma, Marx, Wolfgang, Berk, Michael, Lotfaliany, Mojtaba, Castle, David, Cryan, John F., Athan, Eugene, Hair, Christopher, Nierenberg, Andrew A., Jacka, Felice N., and Dawson, Samantha (2025) Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis. The British Journal of Psychiatry, 226 (3). pp. 171-183.

[img]
Preview
PDF (Published Version) - Published Version
Available under License Creative Commons Attribution.

Download (628kB) | Preview
View at Publisher Website: https://doi.org/10.1192/bjp.2024.121
4


Abstract

Background The prenatal and early-life periods pose a crucial neurodevelopmental window whereby disruptions to the intestinal microbiota and the developing brain may have adverse impacts. As antibiotics affect the human intestinal microbiome, it follows that early-life antibiotic exposure may be associated with later-life psychiatric or neurocognitive outcomes. Aims To explore the association between early-life (in utero and early childhood (age 0–2 years)) antibiotic exposure and the subsequent risk of psychiatric and neurocognitive outcomes. Method A search was conducted using Medline, PsychINFO and Excerpta Medica databases on 20 November 2023. Risk of bias was assessed using the Newcastle-Ottawa scale, and certainty was assessed using the grading of recommendations, assessment, development and evaluation (GRADE) certainty assessment. Results Thirty studies were included (n = 7 047 853 participants). Associations were observed between in utero antibiotic exposure and later development of autism spectrum disorder (ASD) (odds ratio 1.09, 95% CI: 1.02–1.16) and attention-deficit hyperactivity disorder (ADHD) (odds ratio 1.19, 95% CI: 1.11–1.27) and early-childhood exposure and later development of ASD (odds ratio 1.19, 95% CI: 1.01–1.40), ADHD (odds ratio 1.33, 95% CI: 1.20–1.48) and major depressive disorder (MDD) (odds ratio 1.29, 95% CI: 1.04–1.60). However, studies that used sibling control groups showed no significant association between early-life exposure and ASD or ADHD. No studies in MDD used sibling controls. Using the GRADE certainty assessment, all meta-analyses but one were rated very low certainty, largely owing to methodological and statistical heterogeneity. Conclusions While there was weak evidence for associations between antibiotic use in early-life and later neurodevelopmental outcomes, these were attenuated in sibling-controlled subgroup analyses. Thus, associations may be explained by genetic and familial confounding, and studies failing to utilise sibling-control groups must be interpreted with caution. PROSPERO ID: CRD42022304128

Item ID: 88289
Item Type: Article (Research - C1)
ISSN: 1472-1465
Keywords: Antibiotics, attention-deficit hyperactivity disorder, autism spectrum disorder, neurodevelopment, psychiatry
Copyright Information: © The Author(s), 2024. Published by Cambridge University Press on behalf of Royal College of Psychiatrists. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Date Deposited: 08 Apr 2026 06:55
FoR Codes: 32 BIOMEDICAL AND CLINICAL SCIENCES > 3202 Clinical sciences > 320221 Psychiatry (incl. psychotherapy) @ 100%
SEO Codes: 20 HEALTH > 2001 Clinical health > 200105 Treatment of human diseases and conditions @ 100%
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page